Melmed Center
Scottsdale, Arizona, United States
Medical clinic in Phoenix, Arizona
4848 E Cactus Rd #940, Scottsdale, AZ 85254
About Melmed Center
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Akili Interactive Labs, Inc.
5
Shire
3
Noven Therapeutics
2
Cephalon
1
Cognoa, Inc.
1
Lumos Labs, Inc.
1
Stemina Biomarker Discovery, Inc.
1
SynapDx
1
Clinical Trials at Melmed Center
During the past decade, Melmed Center conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 3 clinical trials were completed, i.e. on
average, 37.5% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study to Assess Satisfaction With Modafinil Treatment in Children and Adolescents With ADHD
2005-09-01
2006-09-01
Completed
Evaluate the Efficacy &Safety of Methylphenidate Transdermal System (MTS) in Adolescents Aged 13-17 Years With ADHD
2007-07-01
2008-05-01
Completed
217
Dose-Optimization Study Evaluating the Efficacy, Safety and Tolerability of Vyvanse (Lisdexamfetamine Dimesylate) in Children Aged 6-12 Diagnosed With ADHD
2007-06-28
2008-01-02
Completed
318
Evaluate the Safety and Efficacy of Methylphenidate Transdermal System (MTS) in Adolescents Aged 13-17 Years With ADHD
2007-08-01
2009-02-01
Completed
163
Efficacy and Safety of SPD503 in Combination With Psychostimulants
2008-09-02
2009-12-10
Completed
461
Effectiveness of Vyvanse Compared to Concerta in Adolescents With Attention-deficit/Hyperactivity Disorder
2012-04-17
2014-01-22
Completed
464
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Melmed Center" #1 sponsor was "Akili Interactive Labs, Inc." with 5 trials, followed by "Shire" with 3 trials
sponsored, "Noven Therapeutics" with 2 trials sponsored, "Cephalon" with 1 trials sponsored and "Cognoa, Inc."
with 1 trials sponsored. Other sponsors include -2 different institutions and
companies that sponsored additional 8 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Melmed Center"
#1 collaborator was "Nancy Lurie Marks Family Foundation" with 1 trials as a collaborator and "National Institute of Mental Health (NIMH)" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Melmed Center
According to Clinical.Site data, the most researched conditions in "Melmed Center" are
"ADHD" (5 trials), "Attention Deficit Hyperactivity Disorder" (3 trials), "Attention Deficit Disorder With Hyperactivity" (2 trials), "Autism Spectrum Disorder" (2 trials) and "Attention Deficit Hyperactivity Disorder (ADHD)" (1 trials). Many other conditions were trialed in "Melmed Center" in a lesser frequency.
Clinical Trials Intervention Types at Melmed Center
Most popular intervention types in "Melmed Center" are "Drug" (6 trials), "Device" (5 trials), "Diagnostic Test" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "AKL-T01" (3 trials), "Placebo" (3 trials), "ADHD Therapy" (1 trials), "AKL-T09" (1 trials) and "Cognoa ASD diagnostic device" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Melmed Center
The vast majority of trials in "Melmed Center" are
15 trials for "All" genders.
Clinical Trials Status at Melmed Center
Currently, there are NaN active trials in "Melmed Center".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 13 completed trials in Melmed Center,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Melmed Center, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 7 trials that are defined as “Not Applicable".